CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products based on its proprietary recombinant human collagen (rhCollagen) ...
An international team led by National University of Singapore researchers has linked secondary lymphedema to excessive cholesterol buildup inside skin and around lymphatic vessels. Excess cholesterol ...
Morning Overview on MSN
New light therapy slashes key hair loss marker by 92%
A wearable light therapy device tuned to near-infrared wavelengths has reduced a key cellular aging marker by 92% in laboratory tests on human hair follicle cells, according to new research. The ...
CollPlant is now moving towards clinical trials and scaling and optimizing its manufacturing to ensure readiness for the upcoming clinical trials REHOVOT, Israel, Sept. 30, 2025 /PRNewswire/ -- ...
Collplant Holdings ( (CLGN) ) has issued an announcement.
Please provide your email address to receive an email when new articles are posted on . Two calcium hydroxyapatite-based derma fillers were compared. Filler suspended in carboxymethylcellulose induced ...
Dermal Fillers Market Forecast 2026-2036: Global Revenue to Reach USD 9.9 Billion by 2036 at 3.2% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results